About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Oprm1tm1Jep
targeted mutation 1, John E Pintar
MGI:2179052
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Oprm1tm1Jep/Oprm1tm1Jep B6.129S-Oprm1tm1Jep MGI:4358701
hm2
Oprm1tm1Jep/Oprm1tm1Jep involves: 129S/SvEv MGI:4358621
ht3
Oprm1tm1Jep/Oprm1+ B6.129S-Oprm1tm1Jep MGI:4358702
ht4
Oprm1tm1Jep/Oprm1+ involves: 129S/SvEv MGI:4358622
cx5
Oprd1tm1Jep/Oprd1tm1Jep
Oprm1tm1Jep/Oprm1tm1Jep
Oprm1tm1Jep/Oprm1tm1Jep
involves: 129S/SvEv * 129S2/SvPas MGI:4358720
cx6
Arrb2tm1Rjl/Arrb2tm1Rjl
Oprm1tm1Jep/Oprm1tm1Jep
Tg(Th-Oprm1)4Jtw/0
involves: 129S/SvEv * 129X1/SvJ * C57BL/6 * DBA/2 MGI:4355146
cx7
Oprm1tm1Jep/Oprm1tm1Jep
Tg(Th-Oprm1)4Jtw/0
involves: 129S/SvEv * C57BL/6 * DBA/2 MGI:4355145


Genotype
MGI:4358701
hm1
Allelic
Composition
Oprm1tm1Jep/Oprm1tm1Jep
Genetic
Background
B6.129S-Oprm1tm1Jep
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Oprm1tm1Jep mutation (0 available); any Oprm1 mutation (54 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• following treatment with amphetamine, mice exhibit a greater increase in locomotor activity compared with similarly treated wild-type mice
• 2.5 hours before food access, mice exhibit a reduced increased in running wheel activity prior to food access (food anticipitory behavior) compared with similarly treated wild-type mice
• during the 3 hours feeding period, mice exhibit a lower decrease in running wheel activity compared with similarly treated wild-type mice
• following treatment with amphetamine, mice exhibit a greater increase in locomotor activity compared with similarly treated wild-type mice

nervous system
• midbrain dopamine neurons exhibit lower firing rates and non-bursting activity compared to in wild-type mice with fewer neurons exhibiting fast firing rates
• unlike in wild-type mice, one third of neurons display no bursting at all
• however, the quality of bursting size, burst duration, and frequency of pikes within bursts are normal

adipose tissue
• fat tissue is increased 73% compared to in wild-type mice
• mice exhibit a 5% increased in fat as a percentage of body composition compared with wild-type mice

homeostasis/metabolism
• mice exhibit a 50% increase in pancreas insulin content compared with wild-type mice
• glucose- and tolbutamide-mediated insulin secretion is increased compared to in wild-type islets
• after glucose challenge
• mice exhibit improved glucose tolerance that does not decrease with age

growth/size/body
• while mice exhibit a 11% increase in lean tissue this results is a 5% decrease in lean tissue as a percent of whole body composition compared with wild-type mice
• mice exhibit increased body weight compared with wild-type mice except at birth and during the weaning period (2 to 4 weeks)

endocrine/exocrine glands
• mice exhibit a 50% increase in pancreas insulin content compared with wild-type mice
• glucose- and tolbutamide-mediated insulin secretion is increased compared to in wild-type islets




Genotype
MGI:4358621
hm2
Allelic
Composition
Oprm1tm1Jep/Oprm1tm1Jep
Genetic
Background
involves: 129S/SvEv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Oprm1tm1Jep mutation (0 available); any Oprm1 mutation (54 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• in a tail flick assay, mice treated with morphine, methadone, or DAMGO display nearly no analgesic response unlike in similarly treated wild-type mice (J:52952)
• however, analgesic response to U50,488H, naloxone benzoylhydrazone (NalBzoH), morphine-6beta-glucuronide (M6G), heroine, 6-acetyl-morphine, and D-Penicillamine(2,5)-enkephalin (DPDPE) is normal (J:52952)
• morphine analgesic response is abolished unlike in wild-type mice (J:65217)
• improgan analgesic response is enhanced in female mice compared to in wild-type mice
• however, improgan analgesia in males is normal
• in a tail flick assay, mice treated with morphine, methadone, or DAMGO display nearly no analgesic response unlike in similarly treated wild-type mice (J:52952)
• however, analgesic response to U50,488H, naloxone benzoylhydrazone (NalBzoH), morphine-6beta-glucuronide (M6G), heroine, 6-acetyl-morphine, and D-Penicillamine(2,5)-enkephalin (DPDPE) is normal (J:52952)
• morphine analgesic response is abolished unlike in wild-type mice (J:65217)




Genotype
MGI:4358702
ht3
Allelic
Composition
Oprm1tm1Jep/Oprm1+
Genetic
Background
B6.129S-Oprm1tm1Jep
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Oprm1tm1Jep mutation (0 available); any Oprm1 mutation (54 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• following treatment with amphetamine, mice exhibit a greater increase in locomotor activity compared with similarly treated wild-type mice
• during the 3 hours feeding period, mice exhibit a lower decrease running wheel activity compared with similarly treated wild-type mice
• following treatment with amphetamine, mice exhibit a greater increase in locomotor activity compared with similarly treated wild-type mice




Genotype
MGI:4358622
ht4
Allelic
Composition
Oprm1tm1Jep/Oprm1+
Genetic
Background
involves: 129S/SvEv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Oprm1tm1Jep mutation (0 available); any Oprm1 mutation (54 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• in a tail flick assay, mice exhibit an intermediate analgesic response following morphine, methadone, or DAMGO treatment compared with wild-type and homozygous mice (J:52952)
• however, analgesic response to U50,488H, naloxone benzoylhydrazone (NalBzoH), morphine-6beta-glucuronide (M6G), heroine, 6-acetyl-morphine, and D-Penicillamine(2,5)-enkephalin (DPDPE) is normal (J:52952)
• morphine analgesic response is attenuated compared to in wild-type mice (J:65217)
• improgan analgesic response is enhanced in female mice compared to in wild-type mice
• however, improgan analgesia in males is normal
• in a tail flick assay, mice exhibit an intermediate analgesic response following morphine, methadone, or DAMGO treatment compared with wild-type and homozygous mice (J:52952)
• however, analgesic response to U50,488H, naloxone benzoylhydrazone (NalBzoH), morphine-6beta-glucuronide (M6G), heroine, 6-acetyl-morphine, and D-Penicillamine(2,5)-enkephalin (DPDPE) is normal (J:52952)
• morphine analgesic response is attenuated compared to in wild-type mice (J:65217)




Genotype
MGI:4358720
cx5
Allelic
Composition
Oprd1tm1Jep/Oprd1tm1Jep
Oprm1tm1Jep/Oprm1tm1Jep
Oprm1tm1Jep/Oprm1tm1Jep
Genetic
Background
involves: 129S/SvEv * 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Oprd1tm1Jep mutation (0 available); any Oprd1 mutation (30 available)
Oprm1tm1Jep mutation (0 available); any Oprm1 mutation (54 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
N
• mice exhibit normal nociception prior to opioid infusion
• unlike in wild-type mice, mice exhibit decreased tail-withdrawal latencies demonstrating the abolishment of opioid analgesic responses to acute doses of morphine and oxymorphone
• infusion of morphine results in a decrease in tail withdrawal latency relative to baseline after 2 days unlike similarly treated wild-type mice that display an increase on the first two days and a decrease on days 4 through 7
• infusion of oxymorphone results in reduced tail withdrawal latency compared to baseline at 4 days unlike in similarly treated wild-type mice that exhibit an increase in latency within the first 4 days and a decrease on days 8 through 10
• NMDA receptor blockage with MK-801 does not reverse opioid hyperalgesia unlike in similarly treated wild-type mice
• unlike in wild-type mice, mice exhibit decreased tail-withdrawal latencies demonstrating the abolishment of opioid analgesic responses to acute doses of morphine and oxymorphone
• infusion of morphine results in a decrease in tail withdrawal latency relative to baseline after 2 days unlike similarly treated wild-type mice that display an increase on the first two days and a decrease on days 4 through 7
• infusion of oxymorphone results in reduced tail withdrawal latency compared to baseline at 4 days unlike in similarly treated wild-type mice that exhibit an increase in latency within the first 4 days and a decrease on days 8 through 10
• NMDA receptor blockage with MK-801 does not reverse opioid hyperalgesia unlike in similarly treated wild-type mice

homeostasis/metabolism
• NMDA receptor blockage with MK-801 does not reverse opioid hyperalgesia unlike in similarly treated wild-type mice




Genotype
MGI:4355146
cx6
Allelic
Composition
Arrb2tm1Rjl/Arrb2tm1Rjl
Oprm1tm1Jep/Oprm1tm1Jep
Tg(Th-Oprm1)4Jtw/0
Genetic
Background
involves: 129S/SvEv * 129X1/SvJ * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Arrb2tm1Rjl mutation (2 available); any Arrb2 mutation (27 available)
Oprm1tm1Jep mutation (0 available); any Oprm1 mutation (54 available)
Tg(Th-Oprm1)4Jtw mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• desensitization and internalization of opioid receptors after met-enkephalin treatment is similar to that in controls




Genotype
MGI:4355145
cx7
Allelic
Composition
Oprm1tm1Jep/Oprm1tm1Jep
Tg(Th-Oprm1)4Jtw/0
Genetic
Background
involves: 129S/SvEv * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Oprm1tm1Jep mutation (0 available); any Oprm1 mutation (54 available)
Tg(Th-Oprm1)4Jtw mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• maximum hyperpolarization of neurons induced by met-enkephalin (ME) is similar to that seen in wild-type and transgenic wild-type opioid receptor mutant animals; the EC50 for ME is 50% greater than the transgene-only mutants
• desensitization by ME and recovery of desensitization of receptors is similar to wild-type and transgene-only controls
• desensitization and internalization of the mu-opioid receptor (MOR) in response to various MOR agonists is not different in mutants and controls





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory